Key Events This Week
Jan 5: Technical upgrades signal bullish momentum
Jan 6: Mojo Grade downgraded to Hold amid mixed signals
Jan 7: New 52-week high reached at Rs.1,921.1
Jan 8: Price retreats amid heavy put options activity
Jan 9: Week closes at Rs.1,888.10 (-1.13%)
Why is J B Chemicals & Pharmaceuticals Ltd falling/rising?
2026-01-08 01:58:10
Strong Price Performance Against Benchmarks
The stock has outperformed key market indices and its sector peers over recent periods. Over the past week, J B Chemicals & Pharmaceuticals Ltd gained 6.26%, while the Sensex declined by 0.30%. This positive trend extends to the one-month and year-to-date periods, with the stock rising 6.06% and 6.26% respectively, contrasting with the Sensex’s negative returns. Although the stock’s one-year return of 2.81% trails the Sensex’s 8.65%, its longer-term performance is impressive, with a three-year gain of 98.42% compared to the Sensex’s 41.84%, and a five-year return of 273.82% far exceeding the benchmark’s 76.66%. These figures underscore the company’s sustained growth trajectory and investor confidence over time.
Te...
Read full news article
J B Chemicals & Pharmaceuticals Ltd Hits New 52-Week High at Rs.1921.1
2026-01-07 12:55:58J B Chemicals & Pharmaceuticals Ltd has reached a significant milestone by hitting a new 52-week high of Rs.1921.1, marking a notable moment in the stock’s recent performance and reflecting sustained momentum in the Pharmaceuticals & Biotechnology sector.
Read full news article
J B Chemicals & Pharmaceuticals Ltd Shows Bullish Momentum Amid Technical Upgrades
2026-01-07 08:09:36J B Chemicals & Pharmaceuticals Ltd has demonstrated a notable shift in price momentum, supported by a series of bullish technical signals across multiple timeframes. The stock’s recent performance, coupled with upgrades in its technical trend and a revised Mojo Grade, suggests a cautiously optimistic outlook for investors navigating the Pharmaceuticals & Biotechnology sector.
Read full news article










